Devlin’s research has two primary foci, the development of statistical methods for the analysis of genetic data and the implementation of those methods to discover the genetic basis of disease, especially autism, schizophrenia, and neurodegenerative disorders. His work has been recognized by admission as a fellow to the American Association for the Advancement of Science. He chaired of the Access Committee for the Center for Inherited Disease Research (CIDR), which is a U.S. government-funded genotyping center that performs massive genotyping and sequencing. The CIDR Access Committee or CAC judges the value of proposals for access to CIDR for genomewide association studies, among other kinds of genetic studies.
